LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Court Sides With Spine Arthroplasty Patients in Aetna Lawsuit
Legal & Regulatory and Reimbursement

Court Sides With Spine Arthroplasty Patients in Aetna Lawsuit

July 7, 2021 1 min read Premium comments

Advertisement

Secondary#aetna#classcertification#lumbarartificialdiscreplacement

The United States District Court for the Central District of California has breathed life back into a lawsuit against Aetna Life Insurance Company by granting class certification.

The plaintiffs in this matter include two individuals who were insured by Aetna. They allegedly consulted with surgeons who recommended lumbar artificial disc replacement surgery. According to the allegations, Aetna denied their requests claiming the procedure was “experimental or investigational.”

Plaintiffs are claiming Aetna’s denial policy harmed them. They are “primarily seeking an injunction requiring Aetna to retract its policy that Lumbar ADR [artificial disc replacement] is ‘experimental or investigational.’”

The plaintiffs sought class certification for those individuals covered under Aetna plans governed by Employee Retirement Income Security Act (ERISA). Specifically, those whose requests for lumbar artificial disc replacement surgery Aetna denied because the procedure is “experimental or investigational.” Plaintiffs presented evidence of 239 insureds.

The court granted in substantial part the motion for class certification. It certified the following class: “All persons covered under Aetna Plans, governed by ERISA, self-funded or fully insured, whose requests for lumbar artificial disc replacement surgery were denied at any time within the applicable statute of limitations, or whose requests for that surgery will be denied in the future, on the ground that lumbar artificial disc replacement surgery is experimental or investigational, and whose denials will be subject to abuse of discretion review by the district court.”

Aetna has already filed an appeal. Just two weeks after the order granting class status, Aetna filed an appeal arguing that “[t]he ruling is manifestly erroneous in three ways.”

Aetna claims that the order violates Aetna’s “right to raise contractual defenses to the claims of the individual absent class members.” Next, Aetna argues that the order violates “precedent requiring that ERISA plans be strictly enforced as written.” Finally, Aetna asserts that the court oversimplifies “their class certification analysis.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy